Viramune and Proleukin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viramune (nevirapine) and Proleukin (aldesleukin). Common drug interactions include abdominal pain among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Viramune and Proleukin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Viramune?

Viramune has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 11,381 Viramune users. Check the latest studies of Viramune.

What is Proleukin?

Proleukin has active ingredients of aldesleukin. eHealthMe is studying from 1,865 Proleukin users. Check the latest studies of Proleukin.

On Jul, 14, 2026

12 people who take Viramune and Proleukin together, and have interactions are studied.

Viramune and Proleukin drug interactions.

What are the common drug interactions of Viramune and Proleukin, by gender? *:

female:

Abdominal pain
Asthenia (weakness)
Blood lactate dehydrogenase increased
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hepatocellular damage (liver damage)
Influenza like illness
Pancreatitis (inflammation of pancreas)
Thyroiditis (inflammation of thyroid gland)
Vomiting
Weight decreased

male:

Vomiting
Abdominal discomfort
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Death
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
Abdominal pain

What are the common drug interactions of Viramune and Proleukin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Influenza like illness
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
Vomiting
Abdominal pain
Alveolitis (inflammation in the socket of a tooth)
Asthenia (weakness)
Blood lactate dehydrogenase increased
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Gastrointestinal disorder (functional problems of gastrointestinal tract)

40-49:

Gamma-glutamyltransferase increased
Hepatic failure (liver failure)
Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Vomiting
Cardiac disorder
Cardiomegaly (increased size of heart than normal)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Death
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)

50-59:

Abdominal pain
Blood amylase increased
Cytolytic hepatitis (dissolution or destruction of a liver cell)
Lipase increased
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting

60+:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

* Approximation only. Some reports may have incomplete information.

Do you take Viramune and Proleukin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously